Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors
- PMID: 32860982
- DOI: 10.1016/j.bmcl.2020.127516
Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors
Abstract
The design, synthesis and structure-activity relationships associated with a series of C2-substituted pyrazolopyrimidines as potent allosteric inhibitors of HIV-1 integrase (ALLINIs) are described. Structural modifications to these molecules were made in order to examine the effect on potency and, for select compounds, pharmacokinetic properties. We examined a variety of C2-substituted pyrazolopyrimidines and found that the C2-amide derivatives demonstrated the most potent antiviral activity of this class against HIV-1 infection in cell culture.
Keywords: Allosteric integrase inhibitors; HIV; HIV-1 integrase; LEDGF/p75; Pyrazolopyrimidine.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.J Med Chem. 2020 Mar 12;63(5):2620-2637. doi: 10.1021/acs.jmedchem.9b01681. Epub 2020 Feb 21. J Med Chem. 2020. PMID: 32081010
-
Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrase.Bioorg Med Chem Lett. 2020 Nov 15;30(22):127531. doi: 10.1016/j.bmcl.2020.127531. Epub 2020 Sep 2. Bioorg Med Chem Lett. 2020. PMID: 32890685
-
The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor.Bioorg Med Chem Lett. 2018 Jul 1;28(12):2124-2130. doi: 10.1016/j.bmcl.2018.05.027. Epub 2018 May 14. Bioorg Med Chem Lett. 2018. PMID: 29779976
-
Advances in the development of HIV integrase strand transfer inhibitors.Eur J Med Chem. 2021 Dec 5;225:113787. doi: 10.1016/j.ejmech.2021.113787. Epub 2021 Aug 18. Eur J Med Chem. 2021. PMID: 34425310 Review.
-
Allosteric inhibition of HIV-1 integrase activity.Curr Opin Chem Biol. 2013 Jun;17(3):339-45. doi: 10.1016/j.cbpa.2013.04.010. Epub 2013 May 3. Curr Opin Chem Biol. 2013. PMID: 23647983 Free PMC article. Review.
Cited by
-
Structural aspects of HIV-1 integrase inhibitors: SAR studies and synthetic strategies.Mol Divers. 2024 Dec 17. doi: 10.1007/s11030-024-11068-4. Online ahead of print. Mol Divers. 2024. PMID: 39690291 Review.
-
Identification and Optimization of a Novel HIV-1 Integrase Inhibitor.ACS Omega. 2022 Jan 24;7(5):4482-4491. doi: 10.1021/acsomega.1c06378. eCollection 2022 Feb 8. ACS Omega. 2022. PMID: 35155940 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous